Atlas Trials

A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy

Clinical trial NCT02607124 · TERMINATED

Trial details

NCT number
NCT02607124
Sponsor
Children's Hospital Medical Center, Cincinnati
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
High Grade GliomaDiffuse Intrinsic Pontine GliomaBithalamic High Grade Glioma
Start date
2016-04-01
Primary completion
2018-05-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.